Characterization of Alternative Splicing in High-Risk Wilms' Tumors.
Wilms’ tumors
alternative mRNA splicing
cell deconvolution
pareto task inference
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
20 Apr 2024
20 Apr 2024
Historique:
received:
22
02
2024
revised:
05
04
2024
accepted:
15
04
2024
medline:
27
4
2024
pubmed:
27
4
2024
entrez:
27
4
2024
Statut:
epublish
Résumé
The significant heterogeneity of Wilms' tumors between different patients is thought to arise from genetic and epigenetic distortions that occur during various stages of fetal kidney development in a way that is poorly understood. To address this, we characterized the heterogeneity of alternative mRNA splicing in Wilms' tumors using a publicly available RNAseq dataset of high-risk Wilms' tumors and normal kidney samples. Through Pareto task inference and cell deconvolution, we found that the tumors and normal kidney samples are organized according to progressive stages of kidney development within a triangle-shaped region in latent space, whose vertices, or "archetypes", resemble the cap mesenchyme, the nephrogenic stroma, and epithelial tubular structures of the fetal kidney. We identified a set of genes that are alternatively spliced between tumors located in different regions of latent space and found that many of these genes are associated with the epithelial-to-mesenchymal transition (EMT) and muscle development. Using motif enrichment analysis, we identified putative splicing regulators, some of which are associated with kidney development. Our findings provide new insights into the etiology of Wilms' tumors and suggest that specific splicing mechanisms in early stages of development may contribute to tumor development in different patients.
Identifiants
pubmed: 38674106
pii: ijms25084520
doi: 10.3390/ijms25084520
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Israel Science Foundation
ID : ICORE no. 1902/12 and Grants no. 1634/13, 2017/13, and 1814/20
Organisme : Israel Ministry of Health
ID : Grant no. 3-10146
Organisme : EU-FP7
ID : Marie Curie International Reintegration Grant no. 618592
Organisme : Data Science Institute at Bar-Ilan University
ID : seed grant
Organisme : Israel Cancer Research Fund
ID : Grant no. 19-101-PG
Organisme : Israel Ministry of Science
ID : Grant no. 3-16220
Organisme : Israel Cancer Association
ID : Grant no. 20240114